Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicentre 2x2 factorial randomised study comparing tirofiban administered with the single high-dose bolus versus abciximab and sirolimus eluting stent versus bare metal stent in acute myocardial infarction - MULTI-STRATEGY Trial.

Next Previous
X
Search
Trial Profile

Multicentre 2x2 factorial randomised study comparing tirofiban administered with the single high-dose bolus versus abciximab and sirolimus eluting stent versus bare metal stent in acute myocardial infarction - MULTI-STRATEGY Trial.

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 22 Feb 2014

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Sirolimus (Primary) ; Tirofiban (Primary) ; Abciximab
  • Indications Coronary artery restenosis; Embolism and thrombosis; Myocardial infarction
  • Focus Therapeutic Use
  • Acronyms MULTI-STRATEGY; MULTISTRATEGY

    • Most Recent Events

    • 02 Sep 2010 Long-term, three-year, mortality data from this study have been presented at the European Society of Cardiology (ESC) 2010 meeting in Stockholm, according to an Iroko Cardio International Sarl media release.
    • 29 Aug 2010 3-year-results have been presented at ESC Congress 2010: Annual Congress of the European Society of Cardiology.
    • 14 Mar 2010 Primary endpoint 'ST segment resolution' has been met as per the results presented at the 59th Annual Scientific Session of the American College of Cardiology (ACC-2010).

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top